ASH publications include both clinical and scientific research, and education in the field of hematology.
With an impact factor of 20.3 (2022), Blood is the most cited peer-reviewed publication in the field of hematology. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.
Blood Advances publishes more peer-reviewed hematology research than any other academic journal worldwide and is an online only, open-access journal of the American Society of Hematology, the world’s largest professional society concerned with the causes and treatment of blood disorders. The journal is continuously published, meaning that new articles are added on a daily basis and its impact factor is 7.6 (2022).
Blood Neoplasia is an online-only, open access journal publishing research focused on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, minimal residual disease, and precursor conditions. New content is published continuously.
Blood Vessels, Thrombosis, and Hemostasis (Blood VTH) is an online-only, open access journal publishing research focused on thrombosis, hemostasis, and vascular biology, as well as associated disorders, including hemorrhagic disorders and platelet blood disorders. New content is published continuously.
ASH’s bimonthly member newsletter, The Hematologist: ASH News and Reports, is designed for the broad constituency of ASH, ranging from basic scientists to practicing clinicians. The Hematologist updates readers about important breakthroughs, trials, and literature; publishes expert advice for clinicians; and spotlights the latest ASH programs and initiatives.
ASH Clinical News, a monthly news magazine specifically designed to appeal to clinical practitioners in hematology and oncology, provides timely updates in the field by reporting on key medical meetings, clinical trials, innovative technology, and influential papers in the literature. Regular features include clinical consults, interviews with leaders in various hematology subspecialties, patient education information, news about individual ASH members, and updates on Society initiatives.
The official newspaper of the ASH annual meeting, ASH News Daily highlights each day’s sessions and events.
Hematology, the ASH Education Program, provides in-depth chapters covering each session presented in the ASH annual meeting Education Program.
The ASH-SAP is a high-quality educational product offering up-to-date information in the field of hematology for internists, hematologists, pediatricians, and hematology-oncology fellows.
This compendium features 33 How I Treat articles published in Blood, which have been reviewed and updated to reflect the most recent scientific and clinically relevant information that has come to light since the articles were first published.